−33.5
Edgewise Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−52.6
FY23:
−91.9
FY24:
−109
FY25:
−144
Change from FY21 to FY25
millions USD
FY21:
−242
FY22:
−70.6
FY23:
103
FY24:
−185
FY25:
−32.8
Change from FY21 to FY25
millions USD
FY21:
186
FY22:
130
FY23:
53.2
FY24:
249
FY25:
196
millions USD
FY21:
−89.4
FY22:
6.43
FY23:
64.1
FY24:
−44.4
FY25:
19.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−34.2
FY22:
−58.2
FY23:
−97.7
FY24:
−110
FY25:
−144
All amounts in millions USD